Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca2+-activated Cl− channels
- 18 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pflügers Archiv - European Journal of Physiology
- Vol. 472 (10), 1457-1467
- https://doi.org/10.1007/s00424-020-02434-w
Abstract
An increasing amount of evidence suggests that transmembrane member 16A (TMEM16A)-encoded Ca2+-activated Cl− channels play a crucial role in regulating tumorigenesis. Therefore, specific and potent TMEM16A inhibitors have been proposed to potentially be useful for the treatment of cancer. During drug screening, we found that benzophenanthridine alkaloids (sanguinarine, sanguinarium chloride, sanguinarine nitrate, ethoxysanguinarine, chelerythrine, and dihydrosanguinarine) potently inhibited the recombinant TMEM16A current. The IC50 and Emax values for TMEM16A inhibition of six tested benzophenanthridine alkaloids were 5.6–12.3 μM and 77–91%, respectively. These benzophenanthridine alkaloids also significantly inhibited the endogenous TMEM16A currents and proliferation, migration, and induced apoptosis in LA795 lung adenocarcinoma cells. These data demonstrate that benzophenanthridine alkaloids are novel TMEM16A inhibitors and are potentially useful in specific cancer therapies. These findings also provide new insight for the development of TMEM16A inhibitors.Keywords
Funding Information
- Research Foundation of Education Bureau of Hebei Province (BJ2018030 to XZ)
This publication has 25 references indexed in Scilit:
- The multifaceted role of TMEM16A in cancerCell Calcium, 2019
- Recent advances in TMEM16A: Structure, function, and diseaseJournal of Cellular Physiology, 2018
- Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effectsJournal of Cellular Physiology, 2018
- The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and SignalingPublished by Springer Science and Business Media LLC ,2017
- MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expressionJournal of Experimental & Clinical Cancer Research, 2017
- Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectivesWorld Journal of Gastrointestinal Oncology, 2016
- Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanomaBiochemical Pharmacology, 2009
- TMEM16A, A Membrane Protein Associated with Calcium-Dependent Chloride Channel ActivityScience, 2008
- Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarizationToxicology and Applied Pharmacology, 2007
- Chelerythrine is a potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1990